通过蛋白质激酶CK2控制体重:饮食诱导的肥胖症被药理向药物抵消
Laura M Buchwald1, Ditte Neess1, Daniel Hansen1
1Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Metabolism: clinical and experimental
|November 9, 2024
概括
抑制蛋白激酶CK2可降低饮食诱导肥胖的体重增加和脂肪量. 准CK2可能为治疗肥胖和控制体重提供一种新的策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 蛋白质激酶CK2与肥胖的病原发生有关.
- CK2在调节脂肪代谢中的作用尚不清楚.
研究的目的:
- 研究CK2在脂质代谢中的作用.
- 探索CK2作为肥胖症的治疗点.
主要方法:
- 在实验室中使用小鼠前脂肪细胞的研究.
- 在体内研究,使用饮食诱导肥胖的小鼠模型.
- 使用CX-4945.5进行CK2的药理抑制.
主要成果:
- CK2抑制过早上调 p27KIP1,阻止脂肪细胞的分化.
- CK2调节C/EBPβ表达和酸化,影响脂肪生成.
- 在肥胖小鼠中,CK2抑制降低了体重增加和脂肪量.
结论:
- 在慢性脂质过载期间,CK2在脂肪代谢中起着重要作用.
- 对CK2的药理定位是控制体重和治疗肥胖症的一个有希望的策略.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


